1. Home
  2. TSSI vs ACIU Comparison

TSSI vs ACIU Comparison

Compare TSSI & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TSS Inc.

TSSI

TSS Inc.

HOLD

Current Price

$11.44

Market Cap

275.7M

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.33

Market Cap

221.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSSI
ACIU
Founded
2004
2003
Country
United States
Switzerland
Employees
350
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.7M
221.9M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TSSI
ACIU
Price
$11.44
$2.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$16.00
$10.00
AVG Volume (30 Days)
689.2K
160.8K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$706.75
Revenue Next Year
$3.67
$321.13
P/E Ratio
$42.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.87
$2.03
52 Week High
$21.77
$4.00

Technical Indicators

Market Signals
Indicator
TSSI
ACIU
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
TSSI
ACIU

About TSSI TSS Inc.

TSS Inc provides a comprehensive suite of services for the integration of complex Artificial Intelligence (AI) technologies, planning, design, deployment, maintenance, and refresh of end-user and enterprise systems, including the mission-critical facilities that are housed. It provides a single-source solution for enabling technologies in data centers, operations centers, network facilities, server rooms, security operations centers, communications facilities, and the infrastructure systems that are critical to their functions. Services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: